Karyopharm Therapeutics Stock Price on October 28, 2024

KPTI Stock  USD 0.78  0.03  3.70%   
If you're considering investing in Karyopharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of Karyopharm Therapeutics stands at 0.78, as last reported on the 4th of January, with the highest price reaching 0.83 and the lowest price hitting 0.76 during the day. Karyopharm Therapeutics has Sharpe Ratio of -0.0102, which conveys that the firm had a -0.0102% return per unit of risk over the last 3 months. Karyopharm Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Karyopharm Therapeutics' Mean Deviation of 3.21, standard deviation of 5.16, and Risk Adjusted Performance of 0.001 to check out the risk estimate we provide.
  
Karyopharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0102

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsKPTI

Estimated Market Risk

 5.17
  actual daily
46
54% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Karyopharm Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Karyopharm Therapeutics by adding Karyopharm Therapeutics to a well-diversified portfolio.

Karyopharm Therapeutics Valuation on October 28, 2024

It is possible to determine the worth of Karyopharm Therapeutics on a given historical date. On October 28, 2024 Karyopharm was worth 0.83 at the beginning of the trading date compared to the closed value of 0.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Karyopharm Therapeutics stock. Still, in general, we apply an absolute valuation method to find Karyopharm Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Karyopharm Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Karyopharm Therapeutics' related companies.
 Open High Low Close Volume
  0.83    0.84    0.82    0.83    266,799  
10/28/2024
  0.83    0.90    0.83    0.90    580,856  
  0.88    0.90    0.85    0.85    316,392  
Backtest Karyopharm Therapeutics  |  Karyopharm Therapeutics History  |  Karyopharm Therapeutics Valuation   PreviousNext  
Open Value
0.83
0.9
Closing Value
16.33
Upside

Karyopharm Therapeutics Trading Date Momentum on October 28, 2024

On October 29 2024 Karyopharm Therapeutics was traded for  0.85  at the closing time. The top price for the day was 0.90  and the lowest listed price was  0.85 . The trading volume for the day was 316.4 K. The trading history from October 29, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.56% . The trading delta at closing time against the current closing price is 1.11% .

Karyopharm Therapeutics Fundamentals Correlations and Trends

By evaluating Karyopharm Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Karyopharm Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Karyopharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Karyopharm Therapeutics Stock history

Karyopharm Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Karyopharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Karyopharm Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Karyopharm Therapeutics stock prices may prove useful in developing a viable investing in Karyopharm Therapeutics
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts. Karyopharm Therapeut operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 442 people.

Karyopharm Therapeutics Stock Technical Analysis

Karyopharm Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Karyopharm Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Karyopharm Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Karyopharm Therapeutics Period Price Range

Low
January 4, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Karyopharm Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Karyopharm Therapeutics January 4, 2025 Market Strength

Market strength indicators help investors to evaluate how Karyopharm Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Karyopharm Therapeutics shares will generate the highest return on investment. By undertsting and applying Karyopharm Therapeutics stock market strength indicators, traders can identify Karyopharm Therapeutics entry and exit signals to maximize returns

Karyopharm Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Karyopharm Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Karyopharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Karyopharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Karyopharm Stock analysis

When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon